Still challenging to build a Biotech enterprise in India: Dr Kiran Mazumdar

The eve of April 28, 2016, in Bangalore saw the launch of a book on India’s Biotech icon Dr Kiran Mazumdar-Shaw, the CMD of Asia’s largest Biopharmaceutical enterprise – Biocon


Dr Kiran Mazumdar-Shaw, CMD, Biocon

Titled ‘Mythbreaker -- Kiran Mazumdar-Shaw and the Story of Indian Biotech', and authored by renowned Journalist Ms Seema Singh, the 336-page book chronicles the entire history of Biotechnology in India.

The book has been published by HarperCollins Publishers and is priced at Rs 599.

"This book has been written in such a way that," said Dr Kiran Mazumdar, "everyone one who reads it will find something that they can relate to, and something I'm sure every entrepreneur will relate to. Things haven't changed much in India ever since I became an entrepreneur and started Biocon. It is still very challenging to start and build a biotech company in this country. We have not really done justice to the business of science. This country needs to pay a lot more attention to the power of science and technology. This country has to enable biotechnology and the business of science which are unfortunately not enabled as yet. The ecosystem to build a business based on science and technology is still very challenging in the country."

She says that when it comes to Biotech, it is not just about venture capitalist (VC) funding.

"It is about the regulatory environment, policy enablement and lots of other things which have not been done in our country for this sector. I have spent the last 38 years trying to build this business to bring it to this level, which is Asia's largest biotech enterprise today," she commented.


Previous 1 3 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email